Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
And that’s what we showed more data on that ESMO, last September in Paris.
So when you say that the PRAME dose expansion data are expected by the first half of 2024, is there a chance that it could come later in 2023, maybe at ESMO or one of those conferences?
The data update that we had at ESMO last year clearly shows the potential for vimseltinib to be best-in-class for the treatment of patients with TGCT.